Question 1

Does Berkshire Hathaway own TEVA stock?

Accepted Answer

No. Berkshire Hathaway exited its TEVA (Teva Pharmaceutical Industries) position in Q4 2021. Its Q3 2021 13F listed 42,789,295 shares worth $416.8M.

Question 2

How many shares of TEVA does Berkshire Hathaway own?

Accepted Answer

None since Q4 2021, when Berkshire Hathaway exited the position. Its Q3 2021 13F listed 42,789,295 shares worth $416.8M.

Question 3

What is Berkshire Hathaway's TEVA position worth?

Accepted Answer

Berkshire Hathaway's TEVA position was worth $416.8M in its Q3 2021 13F, before the exit in Q4 2021.

Question 4

Is Berkshire Hathaway buying or selling TEVA?

Accepted Answer

In Q4 2021, Berkshire Hathaway exited its entire TEVA position.

Question 5

When did Berkshire Hathaway first buy TEVA?

Accepted Answer

Berkshire Hathaway already held TEVA in its Q4 2018 13F, the earliest on record, and listed it in 12 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price
2021-Q4 Latest	Exited	0	-100.0%	$0	0.0%	$8.01
2021-Q3	Unchanged	42.8M	0.0%	$416.8M	0.1%	$9.74
2021-Q2	Unchanged	42.8M	0.0%	$423.6M	0.1%	$9.90
2021-Q1	Unchanged	42.8M	0.0%	$493.8M	0.2%	$11.54
2020-Q4	Unchanged	42.8M	0.0%	$412.9M	0.2%	$9.65
2020-Q3	Unchanged	42.8M	0.0%	$385.5M	0.2%	$9.01
2020-Q2	Unchanged	42.8M	0.0%	$527.6M	0.3%	$12.33
2020-Q1	Decreased	42.8M	-1.1%	$384.2M	0.2%	$8.98
2019-Q4	Unchanged	43.2M	0.0%	$423.8M	0.2%	$9.80
2019-Q3	Unchanged	43.2M	0.0%	$297.6M	0.1%	$6.88
2019-Q2	Unchanged	43.2M	0.0%	$399.2M	0.2%	$9.23
2019-Q1	Unchanged	43.2M	0.0%	$678.1M	0.3%	$15.68
2018-Q4	First report	43.2M	-	$666.9M	0.4%	$15.42